Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.172 USD | -4.33% | -13.60% | +11.90% |
07/05 | Transcript : Aclaris Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
07/05 | Earnings Flash (ACRS) ACLARIS THERAPEUTICS Reports Q1 Revenue $2.4M, vs. Street Est of $2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.90% | 87.3M | |
+19.31% | 47.02B | |
+48.77% | 41.86B | |
+0.29% | 41.76B | |
-4.27% | 28.8B | |
+11.62% | 26.05B | |
-22.10% | 19.15B | |
+4.10% | 12.55B | |
+29.25% | 12.34B | |
-4.46% | 11.82B |
- Stock Market
- Equities
- ACRS Stock
- News Aclaris Therapeutics, Inc.
- Goldman Sachs Initiates Aclaris Therapeutics at Buy With $25 Price Target